Response to the Second TNF-α Inhibitor (Adalimumab or Infliximab) after Failing the First One in Refractory Idiopathic Inflammatory Retinal Vascular Leakage
Maleki, Arash, Cristina Garcia, Soheila Asgari, Ambika Manhapra, and Charles Stephen Foster. 2021. “Response to the Second TNF-α Inhibitor (Adalimumab or Infliximab) After Failing the First One in Refractory Idiopathic Inflammatory Retinal Vascular Leakage”. Ocul Immunol Inflamm, 1-10.